| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Revenue  | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 6 | 19 | 36 |
| Expenses | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 6 | 18 | 34 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 | 2 |
| Operating Profit % | 0 % | 4 % | 1 % | 0 % | 0 % | 0 % | -982 % | -200 % | -217 % | 1 % | 6 % | 6 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 | 3 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 | 2 |
| EPS in ₹ | -0.01 | 4.70 | 0.02 | -0.03 | -0.01 | 0.00 | -0.12 | 0.00 | 0.05 | 0.09 | 1.13 | 1.24 |
Gujarat Inject
Gujarat Inject
114.55
+5.45
(5.00%)
Market Cap
167.78 Cr
PE Ratio
87.98
Volume
16,574.00
Day High - Low
114.55 - 110.00
52W High-Low
116.25 - 19.01
Key Fundamentals
Market Cap
167.78 Cr
EPS
1.24
PE Ratio
87.98
PB Ratio
13.50
Book Value
8.08
EBITDA
2.31
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
10.16
Debt to Equity
0.00
Actual
Company News
View All News
Gujarat Inject FY26 Net Profit Rises 78%
May 20, 2026
May 20, 2026Gujarat Inject Kerala Ltd reported a 78.3% rise in net profit to ₹181.41 lakh for FY26. Revenue from operations surged 90.7% to ₹3,632.04 lakh.
Gujarat Inject Kerala Limited's MD Murli Shivshankaran Nair resigns effective May 16, 2026. Deepak Diwan Bachwani elevated from Non-Executive to Whole Time Director and Chairman.
Gujarat Inject (Kerala) Limited receives updated purchase order worth ₹3.11 crores from Earthwave Technology for 3645 solar PV modules to be executed by March 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,788.50 | #1 4,29,121.06 | 37.31 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 44.37 | |
6,576.50 | 1,74,585.41 | 67.49 | 10,560.00 | 8.73 | 2,520 | 13.44 | 46.75 | |
4,368.50 | 1,47,849.89 | 68.30 | 13,753.00 | 19.18 | 2,028 | -26.91 | 50.11 | |
1,375.20 | 1,11,086.00 | 28.84 | 27,711.70 | -2.46 | 3,783 | -55.32 | 52.65 | |
1,076.60 | 1,08,331.15 | 21.16 | 26,719.70 | 13.65 | 5,242 | 7.82 | 68.91 | |
1,263.30 | 1,05,440.45 | 25.59 | 33,593.30 | -0.44 | 3,998 | -86.05 | 41.47 | |
2,261.20 | 1,03,346.61 | #1 19.21 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 45.17 | |
2,369.50 | 97,814.16 | 48.97 | 14,277.60 | 12.03 | 1,750 | 31.75 | 50.42 | |
1,440.40 | 83,658.67 | 23.70 | 33,384.70 | 3.21 | 3,376 | 1.99 | 48.90 | |
1,394.30 | 75,272.20 | 83.88 | 6,812.90 | #1 21.03 | 884 | 21.18 | 76.00 |
Growth Rate
Revenue Growth
89.17 %
Net Income Growth
81.00 %
Cash Flow Change
74.30 %
ROE
947.42 %
ROCE
911.29 %
EBITDA Margin (Avg.)
-3.06 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 12 | 37 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 10 | 12 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 12 | 0 |
| Total Equity & Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 12 | 37 |
| Current Liabilities | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 25 |
| Non Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | -3 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | 9 | 10 | 12 |
| Reserve & Surplus | -8 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -3 | -5 | -3 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 11 | 15 | 15 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | -3 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Activities | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -6 | -2 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | -2 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Apr 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 81.40 % | 80.97 % | 81.10 % | 81.09 % | 81.04 % | 80.92 % | 80.77 % | 81.73 % | 87.18 % | 87.18 % | 87.34 % | 86.70 % | 88.24 % | 86.82 % | 86.79 % | 86.80 % | 85.91 % | 83.95 % | 83.95 % | 92.83 % | 90.02 % | 88.55 % |
| Others | 18.60 % | 19.02 % | 18.90 % | 18.91 % | 18.95 % | 19.08 % | 19.23 % | 18.26 % | 12.82 % | 12.82 % | 12.66 % | 13.30 % | 11.75 % | 13.18 % | 13.21 % | 13.20 % | 14.08 % | 16.05 % | 16.05 % | 7.17 % | 9.98 % | 11.45 % |
| No of Share Holders | 6,367 | 6,365 | 6,364 | 6,365 | 6,366 | 6,353 | 6,333 | 6,341 | 6,551 | 6,551 | 6,633 | 6,775 | 6,721 | 6,706 | 6,698 | 6,627 | 6,773 | 7,303 | 7,303 | 8,151 | 7,826 | 7,853 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 Jan 2024 |  Extraordinary General Meeting | NA | 20 Jan 2024 | 13.00 | 14.30 |
| 28 Sept 2024 |  Annual General Meeting | NA | 28 Sept 2024 | 18.59 | 18.59 |
| 22 Oct 2024 |  Quarterly Result Announcement | NA | 22 Oct 2024 | 18.59 | 17.67 |
| 23 Jan 2025 | Quarterly Result Announcement | NA | 23 Jan 2025 | 26.01 | 25.99 |
| 18 Feb 2025 |  Change Of Name | NA | 18 Feb 2025 | 26.69 | 26.69 |
| 03 Apr 2025 | Extraordinary General Meeting | NA | 03 Apr 2025 | 25.96 | 26.00 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 19.30 | 20.02 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 21.03 | 21.31 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 20.10 | 20.02 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 25.43 | 25.96 |
| 14 Feb 2026 | Quarterly Result Announcement | NA | 14 Feb 2026 | 54.50 | 57.60 |
| 20 May 2026 | Quarterly Result Announcement | NA | 20 May 2026 | 104.80 | 102.90 |
Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media Release9 days ago
9 days agoResults - Financial Results For 31/03/2026May 20, 2026
May 20, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday 20Th May 2026 And Submission Of Audited Financial Results (Standalone) For The Fourth Quarter And Year Ended On 31St March 2026May 20, 2026
May 20, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateMay 16, 2026
May 16, 2026Announcement under Regulation 30 (LODR)-Resignation of Chairman and Managing DirectorMay 16, 2026
May 16, 2026Board Meeting Intimation for Board Meeting For Consideration Of Audited Financial Results For The Quarter & Year Ended 31St March 2026.May 15, 2026
May 15, 2026Closure of Trading WindowMar 30, 2026
Mar 30, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 16, 2026
Mar 16, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 16, 2026
Mar 16, 2026Results - Financial Results For The Quarter Ended On 31/12/2025Feb 14, 2026
Feb 14, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday 14Th February 2026 And Submission Of Un-Audited Financial Results (Standalone) For The Third Quarter And Nine Months Ended On 31St December 2025.Feb 14, 2026
Feb 14, 2026Board Meeting Intimation for Gujarat Inject (Kerala) Limited Scheduled To Be Held On Saturday 14Th February 2026 For Consideration & Approval Of
Un-Audited Financial Results For The Third Quarter And Nine Months Ended On 31St December 2025
Feb 11, 2026
Feb 11, 2026Closure of Trading WindowDec 31, 2025
Dec 31, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorDec 13, 2025
Dec 13, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorDec 09, 2025
Dec 09, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 13Th November 2025Nov 13, 2025
Nov 13, 2025UNAUDITED FINANCIAL RESULTS AS ON 30.09.2025. Nov 13, 2025
Nov 13, 2025Board Meeting Intimation for Un-Audited Financial Results (Standalone) Of The Company For The Quarter And Half Year Ended On 30Th September 2025 Along With Limited Review Report Of The Statutory Auditors Thereon;Nov 10, 2025
Nov 10, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated Thursday 30Th October 2025Oct 30, 2025
Oct 30, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 03, 2025
Oct 03, 2025Closure of Trading WindowOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Sep 30, 2025Reg. 34 (1) Annual Report.Sep 10, 2025
Sep 10, 2025Notice Of 34Th Annual General Meeting Along With Annual Report Of The Company For F.Y. 2024-25.Sep 10, 2025
Sep 10, 2025Board Meeting Outcome for Change Of Object Of The Company.Sep 08, 2025
Sep 08, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 14Th August 2025Aug 14, 2025
Aug 14, 2025FINANCIAL RESULTS 30.06.2025Aug 14, 2025
Aug 14, 2025Board Meeting Intimation for Approval Of Un-Audited Financial Results Of The Company For The Quarter Ended On 30Th June 2025Aug 11, 2025
Aug 11, 2025Revised Outcome Of The Board Meeting Held On 07Th July 2025Jul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-CessationJul 15, 2025
Jul 15, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJul 07, 2025
Jul 07, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated 07Th July 2025Jul 07, 2025
Jul 07, 2025Closure of Trading WindowJul 01, 2025
Jul 01, 2025Execution Of The Investment Sale AgreementJun 30, 2025
Jun 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday 20Th May 2025 And Submission Of
Audited Financial Results (Standalone) For The Fourth Quarter And Year Ended On 31St
March 2025May 20, 2025
May 20, 2025AUDITED FINANCIAL RESULTS -31.03.2025May 20, 2025
May 20, 2025Board Meeting Intimation for Consideration & Approval Of Audited Financial Results.May 15, 2025
May 15, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 05, 2025
Apr 05, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMApr 03, 2025
Apr 03, 2025Closure of Trading WindowMar 31, 2025
Mar 31, 2025EGM TO BE HELD ON 03.04.2025Mar 12, 2025
Mar 12, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday 18Th February 2025 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation. 2015Feb 18, 2025
Feb 18, 2025Board Meeting Intimation for Sub- Division/Split Of The Equity Shares Of The Company.Feb 13, 2025
Feb 13, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday 05Th February 2025 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation. 2015.Feb 05, 2025
Feb 05, 2025Board Meeting Intimation for Sub- Division/Split Of The Equity Shares Of The Company.Feb 01, 2025
Feb 01, 2025Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended On December 31 2024 Along With Limited Review Report (Unmodified Opinion)Jan 23, 2025
Jan 23, 2025Technical Indicators
RSI(14)
Neutral 60.79
ATR(14)
Less Volatile 3.28
STOCH(9,6)
Neutral 77.78
STOCH RSI(14)
Neutral 36.40
MACD(12,26)
Bearish -0.47
ADX(14)
Strong Trend 49.95
UO(9)
Bearish 49.28
ROC(12)
Uptrend And Accelerating 4.10
WillR(14)
Neutral -47.04
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
